Filing Details

Accession Number:
0001209191-16-156547
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-22 16:50:16
Reporting Period:
2016-12-20
Filing Date:
2016-12-22
Accepted Time:
2016-12-22 16:50:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611024 D David Chang C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Evp, R&D, Chief Medical Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-20 1,788 $50.86 25,123 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
  2. Includes 821 shares acquired under the 2014 Employee Stock Purchase Plan (the "ESPP") on February 19, 2016 and 686 shares acquired under the ESPP on August 19, 2016.